CAPLIPOINT — Caplin Point Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹149.50bn
- IN₹141.11bn
- IN₹16.94bn
- 94
- 10
- 91
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 24.65 | ||
| PEG Ratio (f) | 2.08 | ||
| EPS Growth (f) | 13.42% | ||
| Dividend Yield (f) | 0.19% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.7 | ||
| Price to Tang. Book | 5.73 | ||
| Price to Free Cashflow | 62.73 | ||
| Price to Sales | 7.67 | ||
| EV to EBITDA | 21.87 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 21.53% | ||
| Return on Equity | 22.33% | ||
| Operating Margin | 29.59% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 8,632.02 | 10,612.9 | 12,694.1 | 14,667.3 | 16,941 | 19,493.5 | 22,195 | 21.17% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +22.34 | +11.9 | +23.39 | +25.41 | +21.84 | +13.72 | +13.42 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Directors
- C. Paarthipan NEC (62)
- D. Muralidharan CFO
- Vivek Siddharth COO
- Avaneesh Singh CCO
- Dinesh G. CCO
- Sridhar Ganesan MDR (60)
- D. Mishra DRC (59)
- K. John IND
- R Vishwanathan IND
- C K Gariyali NID (72)
- DAMODARAN Sathyanarayanan NID
- V. Thirumalai NID (73)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 16th, 1990
- Public Since
- November 16th, 1994
- No. of Shareholders
- 81,409
- No. of Employees
- 859
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 76,000,000
- Address
- Narbavi, CHENNAI, 600096
- Web
- https://www.caplinpoint.net/
- Phone
- +91 4428156653
- Contact
- G. Venkatram
- Auditors
- Brahmayya & Co.
Upcoming Events for CAPLIPOINT
Q1 2026 Caplin Point Laboratories Ltd Earnings Release
Caplin Point Laboratories Ltd Annual Shareholders Meeting
Similar to CAPLIPOINT
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Caplin Point Laboratories share price?
As of Today at 19:47 UTC, shares in Caplin Point Laboratories are trading at IN₹1,906.70. This share price information is delayed by 15 minutes.
How has the Caplin Point Laboratories share price performed this year?
Shares in Caplin Point Laboratories last closed at IN₹1,906.70 and the price had moved by +45.36% over the past 365 days. In terms of relative price strength the Caplin Point Laboratories share price has outperformed the S&P BSE 100 Index by +34.68% over the past year.
What are the analyst and broker recommendations for Caplin Point Laboratories?
The overall consensus recommendation for Caplin Point Laboratories is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Caplin Point Laboratories dividend yield?
The Caplin Point Laboratories dividend yield is 0.13% based on the trailing twelve month period.
Does Caplin Point Laboratories pay a dividend?
Last year, Caplin Point Laboratories paid a total dividend of IN₹2.50, and it currently has a trailing dividend yield of 0.13%. We do not have any data on when Caplin Point Laboratories is to next pay dividends.
When does Caplin Point Laboratories next pay dividends?
We do not have data on when Caplin Point Laboratories is to next pay dividends. The historic dividend yield on Caplin Point Laboratories shares is currently 0.13%.
How do I buy Caplin Point Laboratories shares?
To buy shares in Caplin Point Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Caplin Point Laboratories?
As of the previous close price of IN₹1,906.70, shares in Caplin Point Laboratories had a market capitalisation of IN₹149.50bn.
Where are Caplin Point Laboratories shares listed?
Here are the trading details for Caplin Point Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: CAPLIPOINT
What kind of share is Caplin Point Laboratories?
Based on an overall assessment of its quality, value and momentum Caplin Point Laboratories is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Caplin Point Laboratories share price forecast for 2025?
The analyst consensus target price for shares in Caplin Point Laboratories is IN₹2,374.77. That is 24.55% above the last closing price of IN₹1,906.70.
Analysts covering Caplin Point Laboratories currently have a consensus Earnings Per Share (EPS) forecast of IN₹68.20 for the next financial year.
Find out moreWhat is the trend in the Caplin Point Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Caplin Point Laboratories. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +6.41%.
As of the last closing price of IN₹1,906.70, shares in Caplin Point Laboratories were trading -3% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Caplin Point Laboratories PE Ratio?
The Caplin Point Laboratories PE ratio based on its reported earnings over the past 12 months is 24.65. The shares last closed at IN₹1,906.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Caplin Point Laboratories?
Caplin Point Laboratories' management team is headed by:
- C. Paarthipan - NEC
- D. Muralidharan - CFO
- Vivek Siddharth - COO
- Avaneesh Singh - CCO
- Dinesh G. - CCO
- Sridhar Ganesan - MDR
- D. Mishra - DRC
- K. John - IND
- R Vishwanathan - IND
- C K Gariyali - NID
- DAMODARAN Sathyanarayanan - NID
- V. Thirumalai - NID